HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hana Park Selected Research

GYKI 52466

8/2021AMPA Receptor Antagonists Facilitate NEDD4-2-Mediated GRIA1 Ubiquitination by Regulating PP2B-ERK1/2-SGK1 Pathway in Chronic Epilepsy Rats.
4/2021Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats.
12/2020Src/CK2/PTEN-Mediated GluN2B and CREB Dephosphorylations Regulate the Responsiveness to AMPA Receptor Antagonists in Chronic Epilepsy Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hana Park Research Topics

Disease

11Status Epilepticus (Complex Partial Status Epilepticus)
02/2021 - 01/2019
8Hepatocellular Carcinoma (Hepatoma)
01/2021 - 12/2010
7Edema (Dropsy)
11/2020 - 01/2019
5Neuroinflammatory Diseases
01/2020 - 04/2016
5Chronic Hepatitis B
10/2015 - 05/2012
4Epilepsy (Aura)
04/2022 - 12/2020
4Neoplasms (Cancer)
06/2019 - 04/2010
3Seizures (Absence Seizure)
04/2021 - 08/2020
2Chronic Hepatitis C
01/2021 - 01/2021
2Liver Neoplasms (Liver Cancer)
11/2020 - 09/2011
2Fibrosis (Cirrhosis)
01/2019 - 12/2016
2Liver Cirrhosis (Hepatic Cirrhosis)
12/2016 - 11/2010
2Hyperargininemia
10/2014 - 11/2013
1Drug Resistant Epilepsy
08/2021
1Necrosis
02/2021
1Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2021
1Gliosis
10/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Rupture
06/2019
1Spontaneous Rupture
06/2019
1Infections
01/2019
1Adnexal Diseases
01/2019
1Postoperative Pain
01/2019
1Carcinoma (Carcinomatosis)
12/2017
1Neoplasm Metastasis (Metastasis)
12/2017
1Breast Neoplasms (Breast Cancer)
12/2017
1Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
12/2016
1Hematocolpos
11/2016
1Uterine Hemorrhage (Uterine Bleeding)
11/2016

Drug/Important Bio-Agent (IBA)

5bardoxolone methylIBA
04/2022 - 01/2019
4AcidsIBA
04/2021 - 01/2019
3GYKI 52466IBA
08/2021 - 12/2020
3perampanelIBA
08/2021 - 12/2020
3AMPA Receptors (AMPA Receptor)IBA
08/2021 - 12/2020
3Glutamic Acid (Glutamate)FDA Link
04/2021 - 08/2020
3Antiviral Agents (Antivirals)IBA
01/2021 - 01/2019
3Laminin ReceptorsIBA
11/2020 - 01/2019
3p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 01/2019
2Aquaporin 4IBA
11/2020 - 11/2019
2Ligand-Gated Ion ChannelsIBA
08/2020 - 01/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 12/2015
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020 - 01/2019
2DystrophinIBA
11/2019 - 01/2019
2Hepatitis B e AntigensIBA
01/2019 - 05/2012
2Tumor Biomarkers (Tumor Markers)IBA
09/2016 - 01/2013
2adefovirIBA
10/2015 - 01/2013
2ArginaseIBA
10/2014 - 11/2013
2acarboxyprothrombin (PIVKA)IBA
02/2014 - 01/2013
2Biomarkers (Surrogate Marker)IBA
02/2014 - 04/2010
2TelbivudineFDA Link
03/2013 - 01/2013
2DNA (Deoxyribonucleic Acid)IBA
05/2012 - 04/2010
1Proteins (Proteins, Gene)FDA Link
04/2022
1Dynamins (Dynamin)IBA
04/2022
1Serine (L-Serine)FDA Link
04/2022
1Pilocarpine (Ocusert)FDA LinkGeneric
04/2021
1Caspase 3 (Caspase-3)IBA
02/2021
1ParvalbuminsIBA
02/2021
1HMGB1 Protein (HMG1)IBA
02/2021
1Actins (F Actin)IBA
01/2021
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2021
1Neurofibromin 2 (Merlin)IBA
01/2021
1S 10 (S-10)IBA
01/2021
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2021
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2020
1Tyrosine (L-Tyrosine)FDA Link
12/2020
1TensinsIBA
12/2020
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2020
1ORALIT (ORS)IBA
11/2020
1Aquaporins (Water Channels)IBA
11/2020
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2020
1Peptides (Polypeptides)IBA
09/2020
1Immunologic Factors (Immunomodulators)IBA
01/2020
1Purinergic P2X7 ReceptorsIBA
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1CationsIBA
01/2020
1U 0126 (UO 126)IBA
11/2019
1TRPC6 Cation ChannelIBA
11/2019
1Threonine (L-Threonine)FDA Link
09/2019
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2019
1RoscovitineIBA
01/2019
1Tenofovir (Viread)FDA Link
01/2019
1Oleanolic AcidIBA
01/2019
1AntioxidantsIBA
01/2019
1Analgesics (Analgesic Drugs)IBA
01/2019
1Laminin (Merosin)IBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1TriterpenesIBA
01/2019
1FumaratesIBA
01/2019
1Lysosomal Membrane ProteinsIBA
01/2019
1EstersIBA
01/2019
1CollagenIBA
12/2016
1C.I. direct red 80IBA
12/2016
1Oral ContraceptivesIBA
11/2016
1Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA
10/2016
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
10/2016

Therapy/Procedure

6Therapeutics
01/2021 - 11/2013
1Hepatectomy
06/2019
1Operative Time
01/2019
1Surgical Instruments (Clip)
01/2019
1Transplantation
12/2016